Feedback / Questions
ELVN-001 - Enliven Therapeutics
https://www.prnewswire.com/news-releases/enliven-reports-positive-initial-phase-1b-data-for-elvn-001-in-cml-and-outlines-2026-clinical-milestones-302655863.html
Jan 8, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next